Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Let-7 miRNA-binding site polymorphism in the KRAS 3UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/− cetuximab

  • Janne B Kjersem1,
  • Tone Ikdahl2,
  • Tormod Guren2,
  • Eva Skovlund3,
  • Halfdan Sorbye4,
  • Julian Hamfjord1,
  • Per Pfeiffer5,
  • Bengt Glimelius6, 7,
  • Christian Kersten8,
  • Hiroko Solvang1,
  • Kjell M Tveit2 and
  • Elin H Kure1Email author
BMC Cancer201212:534

DOI: 10.1186/1471-2407-12-534

Received: 24 July 2012

Accepted: 14 November 2012

Published: 20 November 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
24 Jul 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
1 Aug 2012 Reviewed Reviewer Report - Martin Pichler
7 Sep 2012 Reviewed Reviewer Report - Joanne Weidhaas
12 Oct 2012 Author responded Author comments - Janne Beathe Kjersem
Resubmission - Version 4
12 Oct 2012 Submitted Manuscript version 4
15 Oct 2012 Author responded Author comments - Janne Beathe Kjersem
Resubmission - Version 5
15 Oct 2012 Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
15 Oct 2012 Reviewed Reviewer Report - Martin Pichler
7 Nov 2012 Reviewed Reviewer Report - Joanne Weidhaas
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
14 Nov 2012 Editorially accepted
20 Nov 2012 Article published 10.1186/1471-2407-12-534

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Genetics, Institute for Cancer Research, Oslo University Hospital
(2)
Department of Oncology, Oslo University Hospital
(3)
School of Pharmacy, University of Oslo and the Norwegian Institute of Public Health
(4)
Department of Oncology, Haukeland University Hospital
(5)
Department of Oncology, Odense University Hospital
(6)
Department of Radiology, Oncology and Radiation Science, Uppsala University
(7)
Department of Oncology and Pathology, Karolinska Institutet
(8)
Center for Cancer Treatment, Southern Hospital Trust

Advertisement